TMCnet.com

TMCnet.com
Share

TMCnet.com

 •  December 12

BEVERLY, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that the European Patent Office has granted a European patent for Brilacidin, the Company’s first-in-class defensin-mimetic, in the prevention and control of Oral Mucositis (OM)....

TMCnet.com

 •  November 9

The "Clinical Trial Strategies in Biosimilar Drug Development" report has been added to Research and Markets' offering. As the patent cliff for many blockbuster biologic therapies is approaching, clinical development programs for biosimilar options to those therapies are emerging at a rapid pace. Among the key areas of development is biologics in...

TMCnet.com

 •  October 24

WASHINGTON, Oct. 24, 2017 /PRNewswire/ -- To combat America's rapidly growing opioid and heroin epidemic, the Milken Institute's Lynda and Stewart Resnick Center for Public Health is joining forces with the United States Drug Enforcement Administration (DEA), DEA Educational Foundation and Discovery Education, the leading provider of digital...

TMCnet.com

 •  October 19

The global label-free detection (LFD) market is expected to grow at an impressive CAGR of close to 11% during the forecast period, according to Technavio's latest market research. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006025/en/ In this market research report, Technavio...

TMCnet.com

 •  August 30

Scientist.com, the world's leading marketplace for outsourced scientific services, announced today the launch of the Innovation HubTM, an online repository of cutting-edge life science research tools and services. The Innovation HubTM includes hundreds of the latest advances in gene editing, 3D bioprinting, nanotech, organ on-a-chip, next...

TMCnet.com

 •  August 25

The "Innovative Solutions for Drug Discovery and Development" report has been added to Research and Markets' offering. The latest edition of the Drug Discovery TOE profiles emerging technology platforms, strategic business models and initiatives, breakthrough approvals and trials for drug discovery and development. The role and impact of emerging...

TMCnet.com

 •  June 12

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that several of its experts will discuss key issues facing the industry at the 53rd Drug Information Association (DIA) Annual meeting, held from June 18 to 22, 2017 in Chicago. PAREXEL will hold in-booth presentations and...

TMCnet.com

 •  May 18

Research and Markets has announced the addition of the "Robotics in Drug Discovery" report to their offering. The introduction of automation and robotics into the drug discovery process has greatly enhanced the ability to explore and identify new drug candidates. Numerous chemical compounds can be manufactured and analyzed in a matter of a couple...

TMCnet.com

 •  February 21

Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of disease-driving genes, today announced that its collaborator, Andrew Lowy, M.D., Professor of Surgery and Chief of the Division of Surgical Oncology at the University of California San Diego Moores Cancer Center,...